Alphavac
Payments companies reported to CMS as associated with Alphavac. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Alphavac, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Alphavac
These are the largest totals companies reported as associated with Alphavac. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Dean Ferrera | East Chicago, IN | Interventional Cardiology | $55,139.32 |
| Sabah Butty | Mishawaka, IN | Vascular & Interventional Radiology | $50,555.95 |
| David Zlotnick | Buffalo, NY | Interventional Cardiology | $40,620.17 |
| John Moriarty | Los Angeles, CA | Vascular & Interventional Radiology | $38,065.46 |
| Jaafer Golzar | Oak Lawn, IL | Interventional Cardiology | $31,930.91 |
| Sukhdeep Basra | Houston, TX | Internal Medicine | $28,952.55 |
| David Wong | Humble, TX | Interventional Cardiology | $26,007.31 |
| Sreekumar Madassery | Chicago, IL | Vascular & Interventional Radiology | $25,626.77 |
| Brian Stegman | St Cloud, MN | Interventional Cardiology | $24,084.61 |
| Maximilian Pyko | Indianapolis, IN | Vascular & Interventional Radiology | $22,259.37 |
Prescribed Alphavac?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.